About Us Contact Us

To discuss your treatment options please call 1-800-615-3055 anytime.

Clinical Trials by Facility

Learn More About This Topic: Chat with Us | Email Us

Eastern Regional Medical Center

Safety and Efficacy Study of Gemcitabine Combined With High Dose Intravenous Vitamin C (HDIVC) for Patients With Metastatic Adenocarcinoma of the Pancreas

Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors

A Clinical Study Conducted in Multiple Centers Comparing Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Subjects With Brain Metastases From Non Small Cell Lung Cancer (NSCLC)

Patient Reported Symptoms in Ovarian Cancer (PRECISION)

Midwestern Regional Medical Center

A Phase I/II Study of Carfilzomib as a Replacement for Bortezomib for Multiple Myeloma Patients Failing Bortezomib-Containing Regimens

Randomized, Double-Blind, Multicenter, Phase 2 Trial Comparing Veliparib Plus Carboplatin and Paclitaxel versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Metastatic or Advanced Non-Small-Cell Lung Cancer (NSCLC)

A Randomized, Phase 2 Study of the Efficacy and Tolerability of Veliparib in Combination with Temozolomide or Veliparib in Combination with Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Subjects with BRCA1 or BRCA2 Mutation and Metastatic Breast Cancer

A Phase I/II Study of the Safety and Biological Activity of Intraperitoneal EGEN-001 (IL-12 plasmid formulated with PEG-PEI- Cholesterol lipopolymer) Administered alone and in Combination with Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients who had Previously Received Cytoreductive Surgery plus HIPEC Therapy.

Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury

O-VAX: A Feasibility Study Using a DNP-Modified Autologous Ovarian Tumor Cell Vaccine as Therapy in Ovarian Cancer Patients After Relapse

Seattle Cancer Treatment and Wellness Center

Sipuleucel-T (Provenge) Registry Study in Men with Advanced Prostate Cancer

Southwestern Regional Medical Center

A Phase I/II Study Evaluating the Maximum Tolerated Dose, Bioequivalence/Pharmacokinetics, Safety and Efficacy of Hyperthermia and Thermodox® (Lyso-Thermosensitive Liposomal Doxirubicin) in Patients with Local-Regional Recurrent Breast Cancer

Protocol ET743-SAR-3002 Phase 3b: A Multicenter, Open-Label Single Arm Study of Yondelis(R)(Trabectedin)for Subjects with Locally Advanced or Metastatic Soft Tissue Sarcoma Excluding Leiomyosarcoma and Liposarcoma Who Have Relapse or Are Refractory to Standard of Care

A Randomized Controlled Study of YONDELIS(R)(Trabectedin) or Dacarbazine for the treatment of Advanced Liposarcoma or Leiomyosarcoma Previously Treated With an Anthracycline and Ifosfamide

Protocol Numbe CMT 01-10: Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy.

Evaluation of Hyperthermia and Radiotherapy for the Treatment of Patients with Locally Advanced Tumors of the Pelvis

O-VAX: A Feasibility Study Using a DNP-Modified Autologous Ovarian Tumor Cell Vaccine as Therapy in Ovarian Cancer Patients After Relapse

Western Regional Medical Center

Evaluation of Hyperthermia and Radiotherapy for the Treatment of Patients with Locally Advanced Tumors of the Pelvis

O-VAX: A Feasibility Study Using a DNP-Modified Autologous Ovarian Tumor Cell Vaccine as Therapy in Ovarian Cancer Patients After Relapse

Click to have us call you

Chat Now.We're here 24/7.

First Name Last Name Email Who are you seeking
cancer care for? What type of
insurance do you have? I have read and understand the disclaimer.

Watch Cancer Videos